These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

10472 related items for PubMed ID: 1512464

  • 21. Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine.
    Kramer RA, Greene K, Ahmad S, Vistica DT.
    Cancer Res; 1987 Mar 15; 47(6):1593-7. PubMed ID: 3815359
    [Abstract] [Full Text] [Related]

  • 22. Increased melphalan activity in intracranial human medulloblastoma and glioma xenografts following buthionine sulfoximine-mediated glutathione depletion.
    Friedman HS, Colvin OM, Griffith OW, Lippitz B, Elion GB, Schold SC, Hilton J, Bigner DD.
    J Natl Cancer Inst; 1989 Apr 05; 81(7):524-7. PubMed ID: 2921776
    [Abstract] [Full Text] [Related]

  • 23. Relationship between melanogenesis, glutathione levels and melphalan toxicity in human melanoma cells.
    Benathan M, Alvero-Jackson H, Mooy AM, Scaletta C, Frenk E.
    Melanoma Res; 1992 Dec 05; 2(5-6):305-14. PubMed ID: 1337997
    [Abstract] [Full Text] [Related]

  • 24. Promotion of trans-platinum in vivo effects on renal heme and hemoprotein metabolism by D,L-buthionine-S,R-sulfoximine. Possible role of glutathione.
    Mayer RD, Maines MD.
    Biochem Pharmacol; 1990 May 15; 39(10):1565-71. PubMed ID: 2337413
    [Abstract] [Full Text] [Related]

  • 25. Enhancement of the depigmenting effect of hydroquinone by cystamine and buthionine sulfoximine.
    Bolognia JL, Sodi SA, Osber MP, Pawelek JM.
    Br J Dermatol; 1995 Sep 15; 133(3):349-57. PubMed ID: 8546987
    [Abstract] [Full Text] [Related]

  • 26. Augmentation of cisplatin (DDP) cytotoxicity in vivo by DL-buthionine sulfoximine (BSO) in DDP-sensitive and-resistant rat ovarian tumors and its relation to DNA interstrand cross links.
    Chen G, Zeller WJ.
    Anticancer Res; 1991 Sep 15; 11(6):2231-7. PubMed ID: 1776864
    [Abstract] [Full Text] [Related]

  • 27. Phase I study of continuous-infusion L-S,R-buthionine sulfoximine with intravenous melphalan.
    Bailey HH, Ripple G, Tutsch KD, Arzoomanian RZ, Alberti D, Feierabend C, Mahvi D, Schink J, Pomplun M, Mulcahy RT, Wilding G.
    J Natl Cancer Inst; 1997 Dec 03; 89(23):1789-96. PubMed ID: 9392620
    [Abstract] [Full Text] [Related]

  • 28. Differential sensitivities of murine melanocytes and melanoma cells to buthionine sulfoximine and anticancer drugs.
    Thrall BD, Raha GA, Springer DL, Meadows GG.
    Pigment Cell Res; 1991 Dec 03; 4(5-6):234-9. PubMed ID: 1823927
    [Abstract] [Full Text] [Related]

  • 29. Combined effects of buthionine sulfoximine and cepharanthine on cytotoxic activity of doxorubicin to multidrug-resistant cells.
    Kisara S, Furusawa S, Murata R, Ogata M, Hikichi N, Takayanagi Y, Sasaki K.
    Oncol Res; 1995 Dec 03; 7(3-4):191-200. PubMed ID: 8555653
    [Abstract] [Full Text] [Related]

  • 30. Effect of systemic glutathione depletion by buthionine sulfoximine on sensitivity of murine bladder cancer to cytotoxic agents.
    Lee KE, Mayer RD, Cockett AT.
    Urology; 1989 Dec 03; 34(6):376-80. PubMed ID: 2595883
    [Abstract] [Full Text] [Related]

  • 31. Role of cellular glutathione and glutathione S-transferase in the expression of alkylating agent cytotoxicity in human breast cancer cells.
    Chen G, Waxman DJ.
    Biochem Pharmacol; 1994 Mar 15; 47(6):1079-87. PubMed ID: 8147907
    [Abstract] [Full Text] [Related]

  • 32. The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma.
    Tagde A, Singh H, Kang MH, Reynolds CP.
    Blood Cancer J; 2014 Jul 18; 4(7):e229. PubMed ID: 25036800
    [Abstract] [Full Text] [Related]

  • 33. Synergistic cytotoxicity of buthionine sulfoximine (BSO) and intensive melphalan (L-PAM) for neuroblastoma cell lines established at relapse after myeloablative therapy.
    Anderson CP, Reynolds CP.
    Bone Marrow Transplant; 2002 Aug 18; 30(3):135-40. PubMed ID: 12189530
    [Abstract] [Full Text] [Related]

  • 34. Mechanism(s) regulating inhibition of thymidylate synthase and growth by gamma-L-glutaminyl-4-hydroxy-3-iodobenzene, a novel melanin precursor, in melanogenic melanoma cells.
    Prezioso JA, Damodaran KM, Wang N, Bloomer WD.
    Biochem Pharmacol; 1993 Jan 26; 45(2):473-81. PubMed ID: 8435097
    [Abstract] [Full Text] [Related]

  • 35. Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells.
    Ali-Osman F, Antoun G, Wang H, Rajagopal S, Gagucas E.
    Mol Pharmacol; 1996 Jun 26; 49(6):1012-20. PubMed ID: 8649339
    [Abstract] [Full Text] [Related]

  • 36. Effect of buthionine sulfoximine on toxicity of verapamil and doxorubicin to multidrug resistant cells and to mice.
    Ford JM, Yang JM, Hait WN.
    Cancer Res; 1991 Jan 01; 51(1):67-72. PubMed ID: 1988108
    [Abstract] [Full Text] [Related]

  • 37. Potentiation of doxorubicin cytotoxicity by buthionine sulfoximine in multidrug-resistant human breast tumor cells.
    Dusre L, Mimnaugh EG, Myers CE, Sinha BK.
    Cancer Res; 1989 Feb 01; 49(3):511-5. PubMed ID: 2535960
    [Abstract] [Full Text] [Related]

  • 38. Enhancement of antitumor activity of cisplatin on human gastric cancer cells in vitro and in vivo by buthionine sulfoximine.
    Saikawa Y, Kubota T, Kuo TH, Furukawa T, Tanino H, Watanabe M, Ishibiki K, Kitajima M.
    Jpn J Cancer Res; 1993 Jul 01; 84(7):787-93. PubMed ID: 8370654
    [Abstract] [Full Text] [Related]

  • 39. Establishment of a melphalan-resistant rhabdomyosarcoma xenograft with cross-resistance to vincristine and enhanced sensitivity following buthionine sulfoximine-mediated glutathione depletion.
    Rosenberg MC, Colvin OM, Griffith OW, Bigner SH, Elion GB, Horton JK, Lilley E, Bigner DD, Friedman HS.
    Cancer Res; 1989 Dec 15; 49(24 Pt 1):6917-22. PubMed ID: 2582434
    [Abstract] [Full Text] [Related]

  • 40. Depletion of glutathione in normal and malignant human cells in vivo by buthionine sulfoximine: clinical and biochemical results.
    O'Dwyer PJ, Hamilton TC, Young RC, LaCreta FP, Carp N, Tew KD, Padavic K, Comis RL, Ozols RF.
    J Natl Cancer Inst; 1992 Feb 19; 84(4):264-7. PubMed ID: 1734088
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 524.